Pfizer Director James Quincey Receives Deferred Phantom Stock Units
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Pfizer Inc ($PFE) — Form 4 Filing Update Insider: James Quincey (Director) Type: Acquisition (Award / Deferred Compensation) Security: Phantom Stock Units Shares: 1,351.587 @ $28.67 Total Value: ~$38,750 Ending Beneficial Ownership: 90,670.847 units Significance: Low (Routine director deferred compensation)
Comprehensive Analysis
Insider Transaction Overview
- Reporting Person: James Quincey, Director
- Issuer: Pfizer Inc ($PFE)
- Transaction Date: September 25, 2026
- Transaction Type: Acquisition (Transaction Code
A) - Security: Phantom Stock Units (convertible 1-for-1 to Common Stock upon retirement)
- Shares Acquired: 1,351.587 units at $28.67 per share
- Transaction Value: ~$38,750.00
- Post-Transaction Holdings: 90,670.847 phantom stock units held directly
Analytical Context
This transaction represents an automatic or elective deferral of director fees/compensation into phantom stock units under Pfizer's deferred compensation plan. Because it represents standard board equity retainer compensation rather than an open-market purchase or sale, it carries low trading significance for market participants.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.